Lucid Diagnostics Inc Revenue Growth Rates (LUCD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Lucid Diagnostics Inc   (NASDAQ: LUCD)
 

LUCD's Revenue Growth by Quarter and Year

Lucid Diagnostics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LUCD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1.47
1st Quarter March 1.26
FY 2.73

LUCDs Annual Revenue
Lucid Diagnostics Inc 's Revenue in the fiscal year 2025 $ 4.71 millions
Lucid Diagnostics Inc 's Revenue in the fiscal year 2024 $ 4.35 millions
Lucid Diagnostics Inc 's Revenue in the fiscal year 2023 $ 2.43 millions
Lucid Diagnostics Inc 's Revenue in the fiscal year 2022 $ 0.38 millions
Lucid Diagnostics Inc 's Revenue in the fiscal year 2021 $ 0.50 millions




LUCD Revenue second quarter 2026 Y/Y Growth Comment
Lucid Diagnostics Inc reported Revenue improvement of 27.07% year on year in the second quarter 2026, to $ 1.47 millions, this is lower than Lucid Diagnostics Inc 's recent average Revenue rise of 83.7%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 114 other companies have achieved higher Revenue growth. While Lucid Diagnostics Inc ' s Revenue rise of 27.07% ranks overall at the positon no. 2104 in the second quarter 2026.


LUCD Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 25 % 15.38 % 845.45 %
3rd Quarter September - 3.42 % 50 % 875 %
2nd Quarter June 27.07 % 18.37 % 512.5 % -
1st Quarter March 51.81 % -17 % 122.22 % 136.84 %
FY   - 8.05 % 79.01 % -

Financial Statements
Lucid Diagnostics Inc 's second quarter 2026 Revenue $ 1.47 millions LUCD's Income Statement
Lucid Diagnostics Inc 's second quarter 2025 Revenue $ 1.16 millions Quarterly LUCD's Income Statement


LUCD Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 23.97 % 2.56 % 33.33 %
3rd Quarter September - 4.31 % 19.39 % 387.5 %
2nd Quarter June 16.98 % 39.76 % -2 % -64.44 %
1st Quarter March -16 % -30.83 % -3.85 % 309.09 %
FY (Year on Year)   - 8.05 % 79.01 % -


Back to LUCD Growth rate Comparisons >> Back to LUCD Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #115
Healthcare Sector #315
Overall #2104

Revenue Y/Y Growth Statistics
High Average Low
379.19 % 83.7 % 5.01 %
(Jun 30 2024)   (Sep 30 2025)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #115
Healthcare Sector #315
Overall #2104
Revenue Y/Y Growth Statistics
High Average Low
379.19 % 83.7 % 5.01 %
(Jun 30 2024)   (Sep 30 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Lucid Diagnostics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
392.45 % 37.46 % -100 %
(Sep 30 2023)  


LUCD's II. Quarter Q/Q Revenue Comment
Lucid Diagnostics Inc achieved in the II. Quarter 2026 below company average Revenue jump of 16.98% quarter on quarter, to $ 1.47 millions.

Within Medical Equipment & Supplies industry 28 other companies have achieved higher Revenue quarter on quarter growth. While Lucid Diagnostics Inc 's Revenue growth quarter on quarter, overall rank is 587.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #29
Healthcare Sector #109
Overall #587
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #29
Healthcare Sector #109
Overall #587
Revenue Q/Q Growth Statistics
High Average Low
392.45 % 37.46 % -100 %
(Sep 30 2023)  


LUCD's II. Quarter Q/Q Revenue Comment
Lucid Diagnostics Inc achieved in the II. Quarter 2026 below company average Revenue jump of 16.98% quarter on quarter, to $ 1.47 millions.

Within Medical Equipment & Supplies industry 28 other companies have achieved higher Revenue quarter on quarter growth. While Lucid Diagnostics Inc 's Revenue growth quarter on quarter, overall rank is 587.


Lucid Diagnostics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 5.45 $ 5.13 $ 4.71 $ 4.40 $ 4.36
Y / Y Revenue Growth (TTM) 24.89 % 23.03 % 8.28 % 5.01 % 14.74 %
Year on Year Revenue Growth Overall Ranking # 1131 # 388 # 141 # 136 # 125
Seqeuential Revenue Change (TTM) 6.06 % 9.09 % 6.98 % 0.89 % 4.48 %
Seq. Revenue Growth (TTM) Overall Ranking # 2141 # 2794 # 1808 # 1096 # 376


Cumulative Revenue growth Comment
Although Lucid Diagnostics Inc 's Annual Revenue growth year on year were below company's average 83.7% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 24.89% year on year, from 23.03% in Mar 31 2026.

In the Healthcare sector 209 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 388 to 1131.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 210
Overall # 1131

Revenue TTM Y/Y Growth Statistics
High Average Low
379.19 %
 83.7 %
5.01 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 317
S&P 500 # 2141
Cumulative Revenue growth Comment
Although Lucid Diagnostics Inc 's Annual Revenue growth year on year were below company's average 83.7% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 24.89% year on year, from 23.03% in Mar 31 2026.

In the Healthcare sector 209 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 388 to 1131.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 210
Overall # 1131

Revenue TTM Y/Y Growth Statistics
High Average Low
379.19 %
83.7 %
5.01 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 317
S&P 500 # 2141




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LUCD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Rhythm Pharmaceuticals Inc 46.91%$ 46.911 millions
Axsome Therapeutics Inc 45.54%$ 45.543 millions
Guardant Health Inc 44.33%$ 44.332 millions
Omada Health Inc 43.27%$ 43.273 millions
Mannkind Corporation42.92%$ 42.922 millions
Butterfly Network Inc 42.47%$ 42.466 millions
Beta Bionics Inc 42.26%$ 42.261 millions
Vyne Therapeutics Inc 40.58%$ 40.580 millions
Qhslab Inc 39.98%$ 39.978 millions
Coherus Oncology inc 39.53%$ 39.526 millions
Neurocrine Biosciences Inc 39.49%$ 39.491 millions
Ss Innovations International Inc39.39%$ 39.393 millions
Assembly Biosciences Inc 38.94%$ 38.936 millions
Edap Tms Sa38.85%$ 38.847 millions
Picard Medical Inc 38.62%$ 38.620 millions
Hims and Hers Health Inc 38.41%$ 38.409 millions
Aquestive Therapeutics Inc 38.15%$ 38.149 millions
Mirum Pharmaceuticals Inc 37.92%$ 37.922 millions
Natera Inc 37.71%$ 37.715 millions
Zomedica Corp 36.59%$ 36.588 millions
Kura Oncology Inc 36.54%$ 36.538 millions
Scientific Industries Inc 36.02%$ 36.022 millions
Ceribell Inc 35.85%$ 35.852 millions
Intelligent Bio Solutions Inc 35.78%$ 35.777 millions
The Pennant Group Inc 35.76%$ 35.755 millions
Quanterix Corporation35.42%$ 35.416 millions
Inspiremd Inc 34.88%$ 34.882 millions
The Oncology Institute Inc 34.62%$ 34.624 millions
Agenus Inc34.36%$ 34.358 millions
Biodesix Inc 34.18%$ 34.184 millions


About Lucid Diagnostics Inc Revenue Growth Rates (LUCD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Lucid Diagnostics Inc (CIK 1799011).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-027335
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Lucid Diagnostics Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.